Abstract
Nanotechnologies seem to have huge potential to bring benefits in areas as diverse as drug development, water decontamination, information and communication infrastructures, and the production of stronger, lighter and perfect nanomaterials. This potential attracts global investment from governments and private sectors in nanotechnologies with the hopes that R and commercial applications of nanomaterials, nanodevices, nanoparticles and nanodrugs will provide new impetus, after the ebb-tides of biotechnology and dotcom, to turn faltering economies around. The global governmental funding has been actively promoting industrial and academic cooperation to realize big prosperity from the nanotechnologies. This article summarizes historic trends and status of global governmental supports for nanotechnologies.
Keywords: nanotechnology, governmental nanotechnology funding
Current Nanoscience
Title: Global Governmental Investment in Nanotechnologies
Volume: 1 Issue: 3
Author(s): Lee Jia
Affiliation:
Keywords: nanotechnology, governmental nanotechnology funding
Abstract: Nanotechnologies seem to have huge potential to bring benefits in areas as diverse as drug development, water decontamination, information and communication infrastructures, and the production of stronger, lighter and perfect nanomaterials. This potential attracts global investment from governments and private sectors in nanotechnologies with the hopes that R and commercial applications of nanomaterials, nanodevices, nanoparticles and nanodrugs will provide new impetus, after the ebb-tides of biotechnology and dotcom, to turn faltering economies around. The global governmental funding has been actively promoting industrial and academic cooperation to realize big prosperity from the nanotechnologies. This article summarizes historic trends and status of global governmental supports for nanotechnologies.
Export Options
About this article
Cite this article as:
Jia Lee, Global Governmental Investment in Nanotechnologies, Current Nanoscience 2005; 1 (3) . https://dx.doi.org/10.2174/157341305774642957
DOI https://dx.doi.org/10.2174/157341305774642957 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: Clinical Trials in ANCA Associated Vasculitis (Guest Editor: Chetan Mukhtyar)]
Current Immunology Reviews (Discontinued) Exosomes: Natural Carriers for siRNA Delivery
Current Pharmaceutical Design The Role of Saffron in Attenuating Age-related Oxidative Damage in Rat Hippocampus
Recent Patents on Food, Nutrition & Agriculture New Folate-Modified Human Serum Albumin Conjugated to Cationic Lipid Carriers for Dual Targeting of Mitoxantrone against Breast Cancer
Current Pharmaceutical Biotechnology Chalcones as Versatile Synthons for the Synthesis of 5- and 6-membered Nitrogen Heterocycles
Current Organic Chemistry Identification of Tumor Targeting Agents by Phage Display
Medicinal Chemistry Reviews - Online (Discontinued) Lung Defence Mechanisms and Their Potential Role in the Prevention of Ventilator Associated Pneumonia
Current Respiratory Medicine Reviews Structural Biology of Bacterial Secretion Systems in Gram-Negative Pathogens- Potential for New Drug Targets
Infectious Disorders - Drug Targets The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy
Current Cancer Drug Targets Advances in Targeting Insulin-like Growth Factor Signaling Pathway in Cancer Treatment
Current Pharmaceutical Design The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer
Current Molecular Medicine From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets
Current Pharmaceutical Design ACP5: Its Structure, Distribution, Regulation and Novel Functions
Anti-Cancer Agents in Medicinal Chemistry Polyisoprenylation Potentiates the Inhibition of Polyisoprenylated Methylated Protein Methyl Esterase and the Cell Degenerative Effects of Sulfonyl Fluorides
Current Cancer Drug Targets The Role of Protein Kinase C-alpha (PKC-α) in Cancer and its Modulation by the Novel PKC-α-Specific Inhibitor Aprinocarsen
Current Pharmaceutical Design Niosomal Gel for Site-Specific Sustained Delivery of Anti-Arthritic Drug: In Vitro-In Vivo Evaluation
Current Drug Delivery Urea Derivatives as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry A Review on Antiproliferative and Apoptotic Activities of Natural Honey
Anti-Cancer Agents in Medicinal Chemistry Meganucleases and DNA Double-Strand Break-Induced Recombination: Perspectives for Gene Therapy
Current Gene Therapy